Iosat Tablet
NDC Package 51803-001-01

11-digit billing NDC: 51803000101 · Billing unit: EA · 14 EA per package

Package Information

Iosat (potassium iodide) tablets is use as directed by public officials in the event of a nuclear radiation emergencydo not take more than 1 dose in 24 hourstablets can be whole or crushed and mixed in milk, baby formula, water, orange juice, flat soda like cola, or raspberry syrupThe liquid mixture should be given to infants, young children, and others who cannot swallow tablets; see consumer package insert on how to make a liquid mixture.AgeDoseAdults over 18 years1 tablet (whole or crushed) daily (130 mg)Children over 12 years to 18 years who weigh at least 150 pounds1 tablet (whole or crushed) daily (130 mg)Children over 12 years to 18 years who weigh less than 150 pounds1/2 tablet (whole or crushed) daily (65 mg)Children over 3 years to 12 years1/2 tablet (whole or crushed) daily (65 mg)Children over 1 month to 3 years32.5 mg daily as directed in the consumer package insertBirth to 1 month16.25 mg daily as directed in the consumer package insertIf pregnant, breastfeeding, have a baby up to 1 month of age or have thyroid disease (except nodular thyroid disease with heart disease), take as directed above and contact a doctor as soon as possible. This formulation utilizes a tablet delivery system. Marketed by Anbex Inc., this product is identified by NDC 51803-001 and is authorized under FDA application NDA018664.

Identification & Billing

NDC Package Code
51803-001-01
Package Description
14 TABLET in 1 PACKAGE
Product Code
11-Digit Billing Format
51803000101
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
14 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Iosat
Non-Proprietary Name
Potassium Iodide
Substance Name
Potassium Iodide
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Use as directed by public officials in the event of a nuclear radiation emergencydo not take more than 1 dose in 24 hourstablets can be whole or crushed and mixed in milk, baby formula, water, orange juice, flat soda like cola, or raspberry syrupThe liquid mixture should be given to infants, young children, and others who cannot swallow tablets; see consumer package insert on how to make a liquid mixture.AgeDoseAdults over 18 years1 tablet (whole or crushed) daily (130 mg)Children over 12 years to 18 years who weigh at least 150 pounds1 tablet (whole or crushed) daily (130 mg)Children over 12 years to 18 years who weigh less than 150 pounds1/2 tablet (whole or crushed) daily (65 mg)Children over 3 years to 12 years1/2 tablet (whole or crushed) daily (65 mg)Children over 1 month to 3 years32.5 mg daily as directed in the consumer package insertBirth to 1 month16.25 mg daily as directed in the consumer package insertIf pregnant, breastfeeding, have a baby up to 1 month of age or have thyroid disease (except nodular thyroid disease with heart disease), take as directed above and contact a doctor as soon as possible.

Regulatory & Marketing

Labeler Name
Anbex Inc.
Product Type
Human Otc Drug
FDA Application #
NDA018664
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-14-1982
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (51803-001). Click a package code to view its specific billing and regulatory data.

10 PACKAGE in 1 BAG / 14 TABLET in 1 PACKAGE (51803-001-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51803-001-01 identifies a specific commercial package of 14 tablet in 1 package of Iosat, a human over the counter drug labeled by Anbex Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 14 billable units per package. This tablet is formulated for oral use and contains potassium iodide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Anbex Inc. on October 14, 1982. The current certification is valid through December 31, 2026.

How is this Anbex Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51803000101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 14 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51803-001-01
11-Digit CMS (5-4-2)
51803-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.